NVIVQ — InVivo Therapeutics Holdings Share News
0.000.00%
NASDAQ RESUMED
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
U.S. STOCKS ON THE MOVE-Comstock, Facebook, Southwest Airlines, Ford, AT&T
Biotech CEO, two associates accused by U.S. of securities fraud
Brief: Invivo Therapeutics Files For Offering Of Up To $8 Mln Shares
U.S. STOCKS ON THE MOVE-Netflix, UnitedHealth, Goldman Sachs, Celanese, Chinanet Online, Netlist
U.S. STOCKS ON THE MOVE-Tesla, Twitter, Roku, Chinanet Online, Bellicum Pharma
U.S. STOCKS ON THE MOVE-Express Scripts, Kroger, Zagg, Stage Stores
Brief: Invivo Therapeutics appoints Richard Toselli as chief medical officer
Brief: PixarBio Corporation terminates InVivo Therapeutics bid
Brief: Pixarbio Corp responds to Invivo Therapeutics patent and intellectual property claims
Brief: Invivo Therapeutics says has not discussed offer with PixarBio
Brief: InVivo Therapeutics says entered into a termination agreement of the sales agreement with Cowen and Company, LLC dated as of July 29, 2015
Brief: InVivo Therapeutics announces proposed public offering
Brief: InVivo Therapeutics reports qtrly adj. loss $0.19/shr
Dealtalk: Market turmoil drives small biotechs to big pharma
Brief: InVivo says announces conditional approval for INSPIRE pivotal probable benefit clinical study
Brief: InVivo Therapeutics posts Q3 loss $0.09/shr
Brief: InVivo Therapeutics receives SEC notice of closing of inquiry